- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00965614
To Validate the Specific Patterns of Magnetocardiography, a Non-invasive Non-contact Examination for Patients With Ischemic Heart Disease or Cardiac Arrhythmia
December 20, 2012 updated by: National Taiwan University Hospital
ECG is one of the most important non-invasive method to diagnose CAD and arrhythmia.
However, clinically it still has its limitation.
Because the electrical field could induce a magnetic field, the newly developed non-contact technique, magnetocardiography, was established to detect the local magnetic field component of the heart.
It is safe and more convenient.
In this study, we try to define and validate the magnetocardiographic patterns in the patients with cardiac arrhythmias or ischemia.
Study Overview
Study Type
Expanded Access
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Patient enrollment:
- patients older than 18 years old,
- having received 1) 12-lead ECG examination for suspected cardiac arrhythmias or 2) stress tests for suspected coronary artery disease, will be invited.
- The patients who have medical devices made of metallic or magnetic material (ex. pacemaker, mechanical valve and arthroplasty) will be excluded to prevent the experimental bias.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
August 24, 2009
First Submitted That Met QC Criteria
August 24, 2009
First Posted (Estimate)
August 25, 2009
Study Record Updates
Last Update Posted (Estimate)
December 21, 2012
Last Update Submitted That Met QC Criteria
December 20, 2012
Last Verified
November 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 34MD01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arrhythmia
-
Medical University of LodzNot yet recruitingCardiac Arrhythmia | Supraventricular ArrhythmiaPoland
-
SanofiCompletedVentricular Arrhythmia | Arrhythmia ProphylaxisNetherlands, Spain, Belgium, Japan, Finland, Chile, Australia, United States, Argentina, Canada, Czech Republic, Denmark, France, Germany, Hungary, Israel, Italy, Mexico, Norway, Poland, Portugal, Russian Federation, Slovakia, South Africa and more
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Failure | Arrhythmia | Heart Failure, Congestive | Sinus Arrhythmia
-
Ceryx Medical AustraliaAvaniaNot yet recruitingHeart Failure With Reduced Ejection FractionNew Zealand
-
Ceryx Medical LtdCardiff and Vale University Health BoardNot yet recruitingHeart Failure With Reduced Ejection FractionUnited Kingdom
-
University of Wisconsin, MadisonNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Myant Medical Corp.Partners in Advanced Cardiac EvaluationCompleted
-
New York Institute of TechnologyCompleted
-
Atrial Fibrillation NetworkDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company; Preventicus GmbH; Corsano... and other collaboratorsCompletedAtrial ArrhythmiaGermany, Poland, Spain
-
Population Health Research InstituteBoston Scientific CorporationCompleted
Clinical Trials on MCG
-
Novartis PharmaceuticalsCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveChina
-
MedImmune LLCCompletedRespiratory Syncytial Virus (RSV)United States
-
AMCGNot yet recruitingCoronary Artery DiseaseKorea, Republic of
-
DBV TechnologiesCompletedPeanut AllergyUnited States, Netherlands, France, Canada, Poland
-
Janssen Pharmaceutical K.K.Completed
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUkraine, Slovakia
-
PharmaEssentiaCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Estonia
-
TecnoquimicasDominguezLabCompleted